These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38378497)

  • 1. The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission.
    Hinders DC; Taal AT; Lisam S; da Rocha AM; Banstola NL; Bhandari P; Saha A; Kishore J; Fernandes VO; Chowdhury AS; van 't Noordende AT; Mieras L; Richardus JH; van Brakel WH
    BMC Infect Dis; 2024 Feb; 24(1):226. PubMed ID: 38378497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
    Ortuno-Gutierrez N; Younoussa A; Randrianantoandro A; Braet S; Cauchoix B; Ramboarina S; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Richardus JH; de Jong BC; Hasker E
    BMC Infect Dis; 2019 Dec; 19(1):1033. PubMed ID: 31805862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
    Younoussa A; Samidine SN; Bergeman AT; Piubello A; Attoumani N; Grillone SH; Braet SM; Tsoumanis A; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Snijders R; Corstjens P; Ortuno-Gutierrez N; Hoof C; Geluk A; de Jong BC; Hasker E
    BMC Infect Dis; 2023 May; 23(1):310. PubMed ID: 37161571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.
    Mieras LF; Taal AT; van Brakel WH; Cambau E; Saunderson PR; Smith WCS; Prakoeswa CRS; Astari L; Scollard DM; do Nascimento DC; Grosset J; Kar HK; Izumi S; Gillini L; Virmond MCL; Sturkenboom MGG
    BMC Infect Dis; 2018 Oct; 18(1):506. PubMed ID: 30290790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of leprosy beyond the household level in a highly endemic setting on the Comoros, an observational study.
    Ortuno-Gutierrez N; Baco A; Braet S; Younoussa A; Mzembaba A; Salim Z; Amidy M; Grillone S; de Jong BC; Richardus JH; Hasker E
    BMC Infect Dis; 2019 Jun; 19(1):501. PubMed ID: 31174481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
    Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
    Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial.
    Hasker E; Assoumani Y; Randrianantoandro A; Ramboarina S; Braet SM; Cauchoix B; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Attoumani N; Grillone SH; Ronse M; Peeters Grietens K; Rakoto-Andrianarivelo M; Harinjatovo H; Supply P; Snijders R; Hoof C; Tsoumanis A; Suffys P; Rasamoelina T; Corstjens P; Ortuno-Gutierrez N; Geluk A; Cambau E; de Jong BC
    Lancet Glob Health; 2024 Jun; 12(6):e1017-e1026. PubMed ID: 38762282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
    Barth-Jaeggi T; Steinmann P; Mieras L; van Brakel W; Richardus JH; Tiwari A; Bratschi M; Cavaliero A; Vander Plaetse B; Mirza F; Aerts A;
    BMJ Open; 2016 Nov; 6(11):e013633. PubMed ID: 27856484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing leprosy with retrospective active case finding combined with single-dose rifampicin for contacts in a low endemic setting: results of the Leprosy Post-Exposure Prophylaxis program in Cambodia.
    Cavaliero A; Ay SS; Aerts A; Lay S; So V; Robijn J; Steinmann P
    Acta Trop; 2021 Dec; 224():106138. PubMed ID: 34562427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique and Tanzania.
    Schoenmakers A; Hambridge T; van Wijk R; Kasang C; Richardus JH; Bobosha K; Mitano F; Mshana SE; Mamo E; Marega A; Mwageni N; Letta T; Muloliwa AM; Kamara DV; Eman AM; Raimundo L; Njako B; Mieras L
    BMJ Open; 2021 Aug; 11(8):e046125. PubMed ID: 34446483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy post-exposure prophylaxis in the Indian health system: A cost-effectiveness analysis.
    Tiwari A; Blok DJ; Arif M; Richardus JH
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008521. PubMed ID: 32750059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
    Smith WC; Aerts A
    Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
    Lenz SM; Collins JH; Ray NA; Hagge DA; Lahiri R; Adams LB
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008583. PubMed ID: 32936818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antiphenolic glycolipid-1 antibody levels in seropositive contacts of leprosy after 2 years of single-dose rifampicin as postexposure prophylaxis.
    Jusuf Fantoni OJ; Rusmawardiana ; Yahya YF; Bahar E; Toruan TL; Hari Purwoko MI
    Int J Mycobacteriol; 2023; 12(4):399-406. PubMed ID: 38149534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
    Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
    Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
    Richardus JH; Tiwari A; Barth-Jaeggi T; Arif MA; Banstola NL; Baskota R; Blaney D; Blok DJ; Bonenberger M; Budiawan T; Cavaliero A; Gani Z; Greter H; Ignotti E; Kamara DV; Kasang C; Manglani PR; Mieras L; Njako BF; Pakasi T; Pandey BD; Saunderson P; Singh R; Smith WCS; Stäheli R; Suriyarachchi ND; Tin Maung A; Shwe T; van Berkel J; van Brakel WH; Vander Plaetse B; Virmond M; Wijesinghe MSD; Aerts A; Steinmann P
    Lancet Glob Health; 2021 Jan; 9(1):e81-e90. PubMed ID: 33129378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
    Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
    BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of population-wide screening and mass drug administration for leprosy control in Kiribati: the COMBINE protocol.
    Coleman M; Hill J; Timeon E; Rimon E; Bauro T; Ioteba N; Cunanan A; Douglas NM; Islam T; Tomlinson J; Campbell PO; Williman J; Priest P; Marais BJ; Britton WJ; Chambers ST
    BMJ Open; 2023 Jun; 13(6):e065369. PubMed ID: 37385746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.
    Tiwari A; Dandel S; Djupuri R; Mieras L; Richardus JH
    BMC Infect Dis; 2018 Jul; 18(1):324. PubMed ID: 29996781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.